Table 5. Quantitative characteristics of the category features of the AlOlaiwi2018 diabetes type 2 dataset.

category feature	#	%
albuminuria: macroalbuminuria	18	4.50
albuminuria: microalbuminuria	84	21.00
albuminuria: normoalbuminuria	298	74.50
anti HTN: no	143	35.75
anti HTN: yes	257	64.25
bloating: no	225	56.25
bloating: yes	175	43.75
CAN: no	339	84.75
CAN: yes	61	15.25
DDP-4 inhibitor: no	247	61.75
DDP-4 inhibitor: yes	153	38.25
DR: no	254	63.50
DR: yes	77	36.50
excessive fullness after meals: no	265	66.25
excessive fullness after meals: yes	135	33.75
GCSI category: mild	256	64.00
GCSI category: none	143	35.75
GCSI category: severe	1	0.25
GCSI present: absent	375	93.75
GCSI present: present	25	6.25
HTN: no	239	59.75
HTN: yes	161	40.25
Insulin: no	211	52.75
Insulin: yes	189	47.25
loss of appetitie: no	305	76.25
loss of appetitie: yes	95	23.75
meglitinides: no	399	99.75
meglitinides: yes	1	0.25
metformin: no	22	5.50
metformin: yes	378	94.50
nausea: no	327	81.75
nausea: yes	73	18.25
none: no	398	99.50
none: yes	2	0.50
not able to finish a meal: no	261	75.25
not able to finish a meal: yes	139	34.75
orthostatic hypothension: no	388	97.00
orthostatic hypothension: yes	12	3.00
QTc prolonged: borderline	122	30.50
QTc prolonged: no	247	61.75
QTc prolonged: yes	31	7.75
resting tachycardia: no	377	94.25
resting tachycardia: yes	23	5.75
retching: No	357	89.25
retching: Yes	43	10.75
sex Female	225	56.25
sex Male	175	43.75
smoking 0: no	359	89.75
smoking 1: yes	41	11.25
stomach fullness: no	273	68.25
stomach fullness: yes	127	31.75
stomach or belly visibly larger: no	286	71.25
stomach or belly visibly larger: yes	114	28.75
sulfonylurea: no	202	50.50
sulfonylurea: yes	198	49.50
TZD: no	397	99.25
TZD: yes	3	0.75
vomiting: no	383	95.75
vomiting: yes	17	4.25
total	400	100%

Notes.

^#Number of patients at the medical check-up.

^%Percentage of the patients at the medical check-up.